Profile data is unavailable for this security.
About the company
Beijing Sun-Novo Pharmaceutical Research Co Ltd is a company principally engaged in the provision of preclinical and integrated clinical research and development services for pharmaceuticals. The Company's main businesses cover comprehensive research and development services in drug development, generic drug development and consistency assessment. The Company's services mainly comprise drug discovery, pharmacology and pharmacodynamics, pharmacy research, clinical research and bioanalysis. The Company provides services in pharmacological research, including raw drugs preparation process and structure confirmation, dosage selection, medical services, operational services, data management and statistical analysis services, risk management services and quality management. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)951.95m
- Net income in CNY209.57m
- Incorporated2009
- Employees1.37k
- LocationBeijing Sun-Novo Pharmaceutical Research Co Ltd1F, Building 7, No. 79Shuangying West Road, Science ParkChangping DistrictBEIJING 102200ChinaCHN
- Phone+86 1 060748199
- Fax+86 1 060748199
- Websitehttp://sun-novo.com
More ▼
Mergers & acquisitions
| Acquired company | 688621:SHH since announced | Transaction value |
|---|---|---|
| Chengdu Sintanovo Biotechnology Co Ltd | -50.89% | 16.43m |
Data delayed at least 15 minutes, as of Jul 30 2024 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 384.44m | 26.95m | 2.15bn | 787.00 | 79.54 | 2.95 | -- | 5.59 | 0.0708 | 0.0708 | 1.01 | 1.91 | 0.367 | 1.38 | 1.79 | 488,492.20 | 2.57 | -4.59 | 3.60 | -6.24 | 48.38 | 24.09 | 7.01 | -18.40 | 1.44 | -- | 0.0021 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
| Hinova Pharmaceuticals Inc | 0.00 | -266.00m | 2.39bn | 179.00 | -- | 1.80 | -- | -- | -2.69 | -2.69 | 0.00 | 13.39 | 0.00 | 105.68 | -- | 0.00 | -17.03 | -31.86 | -18.39 | -37.18 | -- | -- | -- | -25,578.24 | 11.83 | -- | 0.0097 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 414.81m | 85.68m | 2.60bn | 566.00 | 25.99 | 2.46 | -- | 6.26 | 0.3602 | 0.3602 | 1.38 | 3.80 | 0.2803 | 0.3898 | 9.21 | 732,874.10 | 5.79 | 8.83 | 6.20 | 9.61 | 60.08 | 61.49 | 20.66 | 26.85 | 8.00 | -- | 0.2519 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Bide Pharmatech Co Ltd | 1.10bn | 98.72m | 2.63bn | 846.00 | 26.59 | 1.28 | -- | 2.38 | 1.09 | 1.09 | 12.14 | 22.50 | 0.4585 | 1.09 | 4.76 | 1,302,686.00 | 4.06 | -- | 4.62 | -- | 38.38 | -- | 8.86 | -- | 5.29 | -- | 0.0416 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Jiangsu Yahong Meditech Co Ltd | 38.05m | -420.35m | 2.81bn | 394.00 | -- | 1.22 | -- | 73.85 | -0.7375 | -0.7375 | 0.0668 | 4.03 | 0.0142 | 3.05 | 3.76 | 96,573.63 | -15.68 | -15.80 | -16.54 | -16.48 | 77.72 | 55.32 | -1,106.10 | -9,445.91 | 11.34 | -- | 0.0684 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| Qingdao Vland Biotech INC | 1.25bn | 82.87m | 3.02bn | 1.57k | 35.93 | 1.76 | -- | 2.41 | 0.3326 | 0.3326 | 5.02 | 6.81 | 0.4431 | 3.42 | 4.33 | 797,663.40 | 3.80 | 5.78 | 5.77 | 7.89 | 45.38 | 46.13 | 8.58 | 10.34 | 0.8387 | 149.27 | 0.2896 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Shanghai Medicilon Inc | 1.17bn | -172.33m | 3.80bn | 2.60k | -- | 1.54 | -- | 3.23 | -1.24 | -1.24 | 9.11 | 18.34 | 0.4205 | 6.63 | 1.64 | 451,437.20 | -6.17 | 9.34 | -7.97 | 11.73 | 12.48 | 36.71 | -14.68 | 14.93 | 2.63 | -- | 0.1229 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.43bn | 117.53m | 3.86bn | 584.00 | 31.95 | 2.13 | -- | 2.69 | 0.7061 | 0.7061 | 8.61 | 10.60 | 0.6264 | 1.66 | 4.42 | 2,451,945.00 | 6.11 | 5.31 | 7.69 | 6.76 | 82.35 | 86.02 | 9.76 | 8.10 | 3.25 | -- | 0.0809 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| HitGen Inc | 409.13m | 64.05m | 3.87bn | 452.00 | 60.33 | 2.81 | -- | 9.46 | 0.1601 | 0.1601 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| InventisBio Co Ltd | 194.13m | -249.28m | 4.09bn | 221.00 | -- | 2.11 | -- | 21.06 | -0.4289 | -0.4289 | 0.3348 | 3.35 | 0.0898 | -- | 1.96 | 878,429.50 | -11.53 | -- | -12.26 | -- | 97.85 | -- | -128.41 | -- | -- | -- | 0.0054 | -- | -- | -- | 41.26 | -- | -- | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 951.95m | 209.57m | 4.11bn | 1.37k | 19.60 | 4.05 | -- | 4.32 | 1.87 | 1.87 | 8.50 | 9.06 | 0.5465 | 26.19 | 1.77 | 694,854.30 | 11.70 | 12.99 | 19.13 | 21.70 | 59.10 | 53.93 | 21.40 | 21.34 | 1.77 | 45.00 | 0.3721 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| GemPharmatech Co Ltd | 638.97m | 157.34m | 4.36bn | 1.51k | 27.72 | 2.05 | -- | 6.83 | 0.3838 | 0.3838 | 1.56 | 5.20 | 0.2617 | 4.11 | 2.36 | 424,282.40 | 6.44 | 9.45 | 7.28 | 11.13 | 66.43 | 70.21 | 24.62 | 28.16 | 4.68 | -- | 0.0592 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
Data as of Jul 30 2024. Currency figures normalised to Beijing Sun-Novo Pharmaceutical Research Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
25.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 10.78m | 12.14% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 3.27m | 4.03% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 2.46m | 3.04% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 1.29m | 1.59% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 1.20m | 1.36% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 948.05k | 1.07% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 690.07k | 0.78% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 583.23k | 0.66% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 507.11k | 0.63% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 360.28k | 0.44% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
